Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1981 1
1983 2
1984 3
1985 1
1986 4
1987 3
1988 2
1989 4
1990 3
1991 3
1992 2
1993 3
1994 2
1995 2
1996 6
1997 4
1998 2
1999 8
2000 5
2001 7
2002 5
2003 8
2004 11
2005 7
2006 11
2007 15
2008 17
2009 16
2010 7
2011 12
2012 15
2013 20
2014 14
2015 24
2016 23
2017 33
2018 27
2019 27
2020 41
2021 32
Text availability
Article attribute
Article type
Publication date

Search Results

397 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, %, %, % The following terms were not found in PubMed: 22Holl, 5BAuthor
Page 1
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
'Worse than death' and waiting for a joint arthroplasty.
Scott CEH, MacDonald DJ, Howie CR. Scott CEH, et al. Bone Joint J. 2019 Aug;101-B(8):941-950. doi: 10.1302/0301-620X.101B8.BJJ-2019-0116.R1. Bone Joint J. 2019. PMID: 31362549 Free PMC article. Clinical Trial.

AIMS: The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general health questionnaire where an EQ-5D < 0 defines a state 'worse than death' (WTD). ...PATIENTS AND METHODS: A cross-sectional analysis of 2073 patients undergoing 2073 T

AIMS: The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general health questionnaire where an EQ-5D
Complications and outcome after rib fracture fixation: A systematic review.
Peek J, Beks RB, Hietbrink F, Heng M, De Jong MB, Beeres FJP, Leenen LPH, Groenwold RHH, Houwert RM. Peek J, et al. J Trauma Acute Care Surg. 2020 Aug;89(2):411-418. doi: 10.1097/TA.0000000000002716. J Trauma Acute Care Surg. 2020. PMID: 32282759
The most frequently used questionnaire to assess patient quality of life was the EuroQol-5D (EQ-5D) (n = 4). Four studies reporting on the EQ-5D had a weighted mean EQ-5D index of 0.80 indicating good quality of life after rib fracture fixation. ...
The most frequently used questionnaire to assess patient quality of life was the EuroQol-5D (EQ-5D) (n = 4). Four studies repo …
A randomized controlled trial of a walking training with simultaneous cognitive demand (dual-task) in chronic stroke.
Meester D, Al-Yahya E, Dennis A, Collett J, Wade DT, Ovington M, Liu F, Meaney A, Cockburn J, Johansen-Berg H, Dawes H. Meester D, et al. Eur J Neurol. 2019 Mar;26(3):435-441. doi: 10.1111/ene.13833. Epub 2018 Nov 25. Eur J Neurol. 2019. PMID: 30308699 Free PMC article. Clinical Trial.
Participants received a 10 week, bi-weekly, 30 min treadmill programme at an aerobic training intensity (55%-85% heart rate maximum), either with or without simultaneous cognitive demands. Outcome was measured at 0, 11 and 22 weeks. The primary assessment involved 2-min wa …
Participants received a 10 week, bi-weekly, 30 min treadmill programme at an aerobic training intensity (55%-85% heart rate maximum), either …
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, Undas A. Bala MM, et al. Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD012169. doi: 10.1002/14651858.CD012169.pub2. Cochrane Database Syst Rev. 2017. PMID: 28968483 Free PMC article. Updated. Review.
One study was at low risk of bias in all domains for objective outcomes but not for quality of life (measured using the EQ-5D-5L questionnaire). We judged the other three studies to be at unclear or high risk of bias in three or more domains.The duration of intervention ra …
One study was at low risk of bias in all domains for objective outcomes but not for quality of life (measured using the EQ-5D-5L ques …
Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins.
Brittenden J, Cooper D, Dimitrova M, Scotland G, Cotton SC, Elders A, MacLennan G, Ramsay CR, Norrie J, Burr JM, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, Tassie E, Francis J, Campbell MK. Brittenden J, et al. N Engl J Med. 2019 Sep 5;381(10):912-922. doi: 10.1056/NEJMoa1805186. N Engl J Med. 2019. PMID: 31483962 Free article. Clinical Trial.
Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models of expected costs and quality-adjusted life-years (QALYs) gained that used data on participants' treatment costs and scores on the EuroQol …
Primary outcomes at 5 years were disease-specific quality of life and generic quality of life, as well as cost-effectiveness based on models …
Peripheral refraction and spherical aberration profiles with single vision, bifocal and multifocal soft contact lenses.
Fedtke C, Ehrmann K, Bakaraju RC. Fedtke C, et al. J Optom. 2020 Jan-Mar;13(1):15-28. doi: 10.1016/j.optom.2018.11.002. Epub 2019 Feb 13. J Optom. 2020. PMID: 30772211 Free PMC article. Clinical Trial.
PURPOSE: To compare the peripheral refraction and spherical aberration profiles along three visual field meridians of 16 commercial single vision (SV), bifocal (BF) and multifocal (MF) test contact lenses with a single vision control. METHOD: Forty-four participants [24.22
PURPOSE: To compare the peripheral refraction and spherical aberration profiles along three visual field meridians of 16 commercial single v …
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.
Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM; CaVenT Study Group. Haig Y, et al. Lancet Haematol. 2016 Feb;3(2):e64-71. doi: 10.1016/S2352-3026(15)00248-3. Epub 2016 Jan 6. Lancet Haematol. 2016. PMID: 26853645 Clinical Trial.
In this study we report results at the 5-year follow-up, aiming to assess whether findings for post-thrombotic syndrome and quality of life have persisted. METHODS: Between Jan 3, 2006, and Dec 22, 2009, we recruited patients aged 18-75 years with a first-time high proxima …
In this study we report results at the 5-year follow-up, aiming to assess whether findings for post-thrombotic syndrome and quality of life …
Seven-day intensive preoperative rehabilitation for elderly patients with lung cancer: a randomized controlled trial.
Lai Y, Huang J, Yang M, Su J, Liu J, Che G. Lai Y, et al. J Surg Res. 2017 Mar;209:30-36. doi: 10.1016/j.jss.2016.09.033. Epub 2016 Sep 28. J Surg Res. 2017. PMID: 28032568 Clinical Trial.

During the preoperative PR, a significantly longer 6-MWD (increase: 28.6 18.2 versus 9.4 27.0 m; between-groups difference: 19.2 m, P = 0.029) and an increased PEF (increase: 26.2 22.5 versus 8.2 10.3 L/min; between-groups difference: 18.0 L/min, P < 0.001

During the preoperative PR, a significantly longer 6-MWD (increase: 28.6 18.2 versus 9.4 27.0 m; between-groups difference: 19.2 m
Creating a Health Utility Value for Birdshot Chorioretinopathy.
Sekaran A, Shamdas M, Barry RJ, Denniston AK, Murray PI. Sekaran A, et al. Ocul Immunol Inflamm. 2020 Sep 18:1-8. doi: 10.1080/09273948.2020.1799034. Online ahead of print. Ocul Immunol Inflamm. 2020. PMID: 32946293
RESULTS: A total of 28 BCR patients (9 M, 19 F; mean age 62 years, range 47-83) were included. There were 22 patients with a logMAR vision of 0.3 or better in both eyes. Mean TTO was 0.90 SD 0.18 (range 0.33-1.0) and mean SG was 0.94 SD 0.14 (range 0.5-1.0). TTO cor …
RESULTS: A total of 28 BCR patients (9 M, 19 F; mean age 62 years, range 47-83) were included. There were 22 patients with a l …
397 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page